651. S5(R3) detection of reproductive and developmental toxicity for human pharmaceuticals Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2021 Subject(s): Drug-Related Side Effects and Adverse ReactionsReproductive Physiological Phenomena -- drug effectsToxicity TestsUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
652. Working children: federal injury data and compliance strategies could be strengthened : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2018 Subject(s): Occupational Injuries -- statistics & numerical dataAdolescentOccupational Injuries -- mortalityUnited StatesUnited States. Department of Labor.
653. E2B(R3) electronic transmission of Individual Case Safety Reports (ICSRs) implementation guide: data elements and message specification Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2022 Subject(s): Adverse Drug Reaction Reporting SystemsDrug and Narcotic ControlElectronic MailUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
654. Unwanted sexual behavior: improved guidance, access to care, and training needed to better address victims’ behavioral health needs : report to congressional requesters Publication: Washington, DC : United States Government Accountability Office, August 2023 Subject(s): Government RegulationLegislation, MedicalMilitary Health -- legislation & jurisprudenceSex Offenses -- prevention & controlSexual Harassment -- prevention & controlUnited StatesUnited States. Department of DefenseUnited States. Department of Veterans Affairs